@article{37da400903a84aceae3673345b7433ea,
title = "Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial",
author = "Khan, \{Sadiya S.\} and Anubha Agarwal and Ayers, \{Colby R.\} and Eunsook Jin and Neeland, \{Ian J.\}",
note = "Funding Information: Grant Support: This work was supported by the National Institutes of Health (NIH) grants K23DK106520 to Dr Neeland and R01DK099289 to Dr Jin and CTSA NIH grant UL1TR001105 to UT Southwestern Medical Center. Dr Khan was supported by funding from the NIH (grants P30AG059988 and 5P30DK0929) and the American Heart Association (19TPA34890060). Funding Information: Potential Competing Interests: Dr Neeland has received consulting income from Merck and Nestle Health Sciences, honoraria, consulting, speaking fees, and travel support from Boehringer-Ingelheim/Lilly Alliance, a research grant from Novo Nordisk, and is a former member of the scientific advisory board of AMRA Medical. The other authors declared no conflict of interest. ",
year = "2021",
month = aug,
doi = "10.1016/j.mayocp.2021.06.012",
language = "English",
volume = "96",
pages = "2282--2284",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
number = "8",
}